GOLDMAN SACHS GROUP INC

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 886982 NEW YORK, NY

Back to IOVA Full portfolio

Position in IOVA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$21,200,747

-$9,547,062 QoQ

Shares Held

5,096,334

-41.8% QoQ

Ownership

1.13%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#11

of 292 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 99% Shared 1% None 0%

Common Shares in IOVA Over Time

Shares Held

Position Value (USD)

Derivatives in IOVA

reported options exposure · as of Dec 31, 2024

CallValue

$1,184,000

CallShares

160,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. IOVA ranks #110 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,481,761	$1,232,765,138
2	REGN	Regeneron Pharmaceuticals, Inc.	1,163,191	$725,296,113
3	ROIV	Roivant Sciences Ltd.	18,556,458	$656,713,046
4	TECH	BIO-TECHNE Corp	7,343,324	$518,805,838
5	RVMD	Revolution Medicines, Inc.	2,133,101	$399,487,154
6	MRNA	Moderna, Inc.	4,671,950	$327,176,656
7	TNGX	Tango Therapeutics, Inc.	9,980,620	$311,994,180
8	INCY	Incyte Corp	2,305,782	$261,383,446

All Filings in IOVA

Export CSV

33 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,200,747	5,096,334	-41.8%	Shares	Defined	2026-08-14
2026-03-31	$30,747,809	8,760,060	+1.8%	Shares	Defined	2026-05-15
2025-12-31	$23,498,648	8,607,564	+30.9%	Shares	Defined	2026-03-25
2025-09-30	$14,268,838	6,575,502	+38.4%	Shares	Defined	2025-11-14
2025-06-30	$8,169,786	4,749,876	-14.8%	Shares	Defined	2025-08-14
2025-03-31	$18,554,433	5,571,902	+35.6%	Shares	Defined	2025-06-27
2024-12-31	$30,414,413	4,110,056	-6.4%	Shares	Defined	2025-02-11
2024-12-31	$1,184,000	160,000	+620.7%	Call	Defined	2025-02-11
2024-09-30	$41,222,399	4,390,032	+67.4%	Shares	Defined	2024-11-14
2024-06-30	$21,026,706	2,621,784	-30.7%	Shares	Defined	2024-08-13
2024-03-31	$56,057,582	3,782,563	+2.7%	Shares	Defined	2024-05-15
2023-12-31	$29,931,082	3,681,560	-2.2%	Shares	Defined	2024-05-14
2023-09-30	$17,124,551	3,763,638	+6.5%	Shares	Defined	2024-05-15
2023-06-30	$24,888,278	3,535,267	-10.1%	Shares	Defined	2024-05-14
2023-03-31	$24,030,531	3,932,984	+8.0%	Shares	Defined	2024-05-14
2022-12-31	$23,279,184	3,643,065	+21.6%	Shares	Defined	2024-05-14
2022-09-30	$28,691,898	2,994,979	+53.4%	Shares	Defined	2024-05-14
2022-06-30	$21,553,899	1,952,346	+239.9%	Shares	Defined	2024-05-14
2022-03-31	$9,563,276	574,371	-60.4%	Shares	Defined	2022-05-16
2022-03-31	$416,250	25,000	+12.6%	Put	Defined	2022-05-16
2021-12-31	$423,798	22,200	-44.5%	Put	Defined	2022-02-17
2021-12-31	$27,676,757	1,449,804	+15.5%	Shares	Defined	2022-02-17
2021-12-31	$423,798	22,200	-44.5%	Call	Defined	2022-02-17
2021-09-30	$30,950,765	1,255,100	-23.6%	Shares	Defined	2022-01-20
2021-06-30	$1,040,800	40,000	-33.3%	Put	Defined	2021-08-13
2021-06-30	$1,040,800	40,000	—	Call	Defined	2021-08-13
2021-06-30	$42,739,878	1,642,578	-14.3%	Shares	Defined	2021-08-13
2021-03-31	$60,708,334	1,917,509	+157.1%	Shares	Defined	2021-05-17
2020-12-31	$34,603,728	745,770	-9.0%	Shares	Defined	2021-02-12
2020-09-30	$26,966,450	819,151	-42.8%	Shares	Defined	2020-11-13
2020-06-30	$39,289,870	1,431,325	+33.9%	Shares	Defined	2020-08-12
2020-03-31	$31,994,122	1,068,608	—	Shares	Defined	2020-05-15
2020-03-31	$1,796,400	60,000	—	Put	Defined	2020-05-15
No filing history on record for this holder in this stock.